ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 191 filers reported holding ARRAY BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $404,000 | -58.6% | 48,242 | -66.7% | 0.01% | -60.0% |
| Q3 2016 | $977,000 | +681.6% | 144,790 | +314.4% | 0.02% | +650.0% |
| Q2 2016 | $125,000 | +115.5% | 34,938 | +77.5% | 0.00% | +100.0% |
| Q1 2016 | $58,000 | -98.2% | 19,681 | -97.4% | 0.00% | -96.0% |
| Q4 2015 | $3,228,000 | +2327.1% | 764,636 | +4039.0% | 0.02% | +1150.0% |
| Q2 2015 | $133,000 | -85.6% | 18,474 | -90.6% | 0.00% | -83.3% |
| Q4 2014 | $925,000 | +161.3% | 195,712 | +151.4% | 0.01% | +200.0% |
| Q2 2013 | $354,000 | – | 77,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |